Dialysis News and Research

Latest Dialysis News and Research

BWH, HSCI establish new method for making kidney structures from stem cells derived from patients

Investigators at Brigham and Women's Hospital and the Harvard Stem Cell Institute have established a highly efficient method for making kidney structures from stem cells that are derived from skin taken from patients.

19 Oct 2015

New $6.7 million project aims to help kidney dialysis patients live longer

Helping kidney dialysis patients have healthier treatment sessions and longer lives is the goal of a new $6.7 million project at the University of Michigan.

15 Oct 2015

Rogosin selected to participate in new Comprehensive End-Stage Renal Disease Care Model

The Rogosin Institute, a NYC-based non-profit provider of comprehensive kidney care, including dialysis for patients with end-stage renal disease (ESRD), has been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in the new Comprehensive End-Stage Renal Disease Care (CEC) Model established by CMMI, CMS's Center for Innovation.

15 Oct 2015

Boehringer Ingelheim, Lilly announce availability of Synjardy tablets in U.S. pharmacies

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced that Synjardy (empagliflozin/metformin hydrochloride) tablets are now available by prescription in pharmacies across the United States.

14 Oct 2015

DaVita plans to start operations in Brazil

DaVita HealthCare Partners Inc., a leading global provider of kidney care services and a leading independent medical group in the United States, today announced plans to begin operations in Brazil. The company, which operates in 11 countries serving more than 1.5 million patients, aims to bring its global expertise and leading clinical outcomes to the country.

30 Sep 2015

University of Michigan-led team performs first kidney transplants in Ethiopia

A University of Michigan-led team performed the first kidney transplants in Ethiopia last week, after spending more than two years to help establish a transplant center in the African country.

30 Sep 2015

Promising drug candidate for chronic intractable itch

If you have an itch, you have to scratch it. But that’s a problem for people with a condition called “chronic intractable itch,” where that itchy sensation never goes away—a difficult-to-treat condition closely associated with dialysis and renal failure.

28 Sep 2015

Researchers develop biophysical treatment method for dialysis patients

Researchers at Charité -- Universitätsmedizin Berlin have developed a biophysical treatment method that allows up to 50 percent more toxins to be removed from the blood of dialysis patients. Use of this technology may result in patients with kidney disease seeing a considerable reduction in the length of dialysis sessions. An initial patent application for this technology was filed in 2011.

21 Sep 2015

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen and Xencor, Inc. announced today that the two companies have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas of cancer immunotherapy and inflammation.

16 Sep 2015

Winners of Renal Support Network's 13th Annual Essay Contest announced

Now in its 13th year of providing a voice for people who have kidney disease and are passionate about writing, Renal Support Network announces the winners of its 13th Annual Essay Contest.

16 Sep 2015

Ninth annual Tour DaVita bike event to be held in NC to raise awareness on kidney disease

DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, announces North Carolina as the host of the ninth annual Tour DaVita bike event.

15 Sep 2015

UT Southwestern evaluates allopurinol drug to prevent nephropathy in Type I diabetes patients

UT Southwestern Medical Center has joined an international clinical trial studying whether a drug traditionally used to treat gout can help prevent kidney damage in patients with Type 1 diabetes.

15 Sep 2015

Sun Biomedical begins DMX-200 Phase II trial for treatment of chronic kidney disease

Sun Biomedical Limited today announced the first patient had been enrolled in a Phase II study of DMX-200, an innovative new treatment that combines two different drugs to treat chronic kidney disease.

15 Sep 2015

Study may help scientists to better understand complications caused by drug therapy in kidney transplant patients

New research will help scientists and medical professionals to better understand the long-term complications caused by an immunosuppressant drug used to treat thousands of kidney transplant patients.

11 Sep 2015

DCR launches Biospecimen Research Grant Program

DaVita Clinical Research, a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen Research Grant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research.

8 Sep 2015

TMIGD1 protein could be a novel target for restoring kidney function from kidney disease

A new discovery by Boston University School of Medicine (BUSM) researchers may change how kidney disease is treated in the future.

3 Sep 2015

Amgen announces MAA submission to EMA for novel calcimimetic agent etelcalcetide

Amgen today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency via the centralized procedure for etelcalcetide (formerly AMG 416) for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on hemodialysis therapy. If approved, etelcalcetide will be the first calcimimetic agent that can be administered intravenously.

3 Sep 2015

Sanofi terminates option and license agreement for Ardelyx's portfolio of NaP2b inhibitors

Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, today announced that Sanofi notified Ardelyx of its termination of the option and license agreement for Ardelyx's portfolio of NaP2b inhibitors effective September 30, 2015.

2 Sep 2015

DaVita Kidney Care to establish kidney care specialty hospital chain in Shandong province China

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading global provider of kidney care services, today announced it is forming a joint venture kidney care specialty hospital chain in Shandong province China.

31 Aug 2015

Symic receives $1.5M NIH Phase II SBIR grant to develop AVF therapeutic candidate

Platform therapeutic company Symic Biomedical, Inc. announced today that it has received a $1.5M Phase II SBIR grant from the National Institutes of Health to further develop its therapeutic agent to reduce arteriovenous fistula (AVF) failures, a significant unmet clinical need in end stage renal disease (ESRD) patients undergoing hemodialysis.

27 Aug 2015

Dialysis News and Research

Latest Dialysis News and Research

BWH, HSCI establish new method for making kidney structures from stem cells derived from patients

New $6.7 million project aims to help kidney dialysis patients live longer

Rogosin selected to participate in new Comprehensive End-Stage Renal Disease Care Model

Boehringer Ingelheim, Lilly announce availability of Synjardy tablets in U.S. pharmacies

DaVita plans to start operations in Brazil

University of Michigan-led team performs first kidney transplants in Ethiopia

Promising drug candidate for chronic intractable itch

Researchers develop biophysical treatment method for dialysis patients

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Winners of Renal Support Network's 13th Annual Essay Contest announced

Ninth annual Tour DaVita bike event to be held in NC to raise awareness on kidney disease

UT Southwestern evaluates allopurinol drug to prevent nephropathy in Type I diabetes patients

Sun Biomedical begins DMX-200 Phase II trial for treatment of chronic kidney disease

Study may help scientists to better understand complications caused by drug therapy in kidney transplant patients

DCR launches Biospecimen Research Grant Program

TMIGD1 protein could be a novel target for restoring kidney function from kidney disease

Amgen announces MAA submission to EMA for novel calcimimetic agent etelcalcetide

Sanofi terminates option and license agreement for Ardelyx's portfolio of NaP2b inhibitors

DaVita Kidney Care to establish kidney care specialty hospital chain in Shandong province China

Symic receives $1.5M NIH Phase II SBIR grant to develop AVF therapeutic candidate

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in